Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV

Mise à jour : Il y a 4 ans
Référence : NCT00596752

Femme et Homme

Extrait

The study is to confirmatorily show a superior effect of Alprostadil compared to placebo on the rate of complete healing of ischemic necroses and ulcerations as well as on the frequency and height of major amputations in patients suffering from PAOD stage IV.


Critère d'inclusion

  • Peripheral arterial occlusive disease


Liens